biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by wesdevrieson Nov 12, 2013 8:22am

102 Views

Post# 21896594

RE:RE:RE:RE:HillBilly's Radio show

Heh, mp4 blow boy...if you want to spam my phone #...think again...carefully... if you want to continue!

I must of really got under-neath your skin; we all know you and your big mouth did not show up at the golf course...although there was an volcano orange Hyundai in the parking lot! You must be the clean-up ball boy! And that makes me smile! You're easy dr. j....you're easy and so predictable!

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages